Peroxiredoxin 4: A multifunctional biomarker worthy of further exploration

BMC Medicine

Volumn 9, Issue , 2011, Pages

  Schulte, Janin ^a  

^a THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIREDOXIN 4; BIOLOGICAL MARKER; PEROXIREDOXIN;

DISEASE MODEL; ENZYME MODIFICATION; HUMAN; MEDICAL RESEARCH; NONHUMAN; NOTE; OBSERVATIONAL STUDY; OLIGOMERIZATION; OXIDATION REDUCTION REACTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; ANIMAL; ARTICLE; BIOLOGICAL MODEL; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIREDOXINS; PROGNOSIS;

EID: 84155191008     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-9-137     Document Type: Note

References (53)

1. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52(4):601-623. 10.1373/clinchem.2005.061408, 16484333.
2. Haridas V, Ni J, Meager A, Su J, Yu GL, Zhai Y, Kyaw H, Akama KT, Hu J, Van Eldik L, Aggarwal BB. TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase. J Immunol 1998, 161(1):1-6.
3. Tavender TJ, Bulleid NJ. Peroxiredoxin IV protects cells from oxidative stress by removing H2O2 produced during disulphide formation. J Cell Sci 2010, 123(Pt 15):2672-2679. 2908052, 20627953.
4. Jin D-Y, Chae HZ, Rhee SG, Jeang K-T. Regulatory role for a novel human thioredoxin peroxidase in NF-kB activation. J Biol Chem 1997, 272(49):30952-30961. 10.1074/jbc.272.49.30952, 9388242.
5. Wood ZA, Schröder E, Harris JR, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003, 28(1):32-40. 10.1016/S0968-0004(02)00003-8, 12517450.
6. Yu S, Mu Y, Ao J, Chen X. Peroxiredoxin IV regulates pro-inflammatory responses in large yellow croaker (Pseudosciaena crocea) and protects against bacterial challenge. J Proteome Res 2010, 9(3):1424-1436. 10.1021/pr900961x, 20099887.
7. Rhee SG, Woo HA. Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H2O2, and protein chaperones. Antioxid Redox Signal 2011, 15(3):781-794. 10.1089/ars.2010.3393, 20919930.
8. O'Neill JS, Reddy AB. Circadian clocks in human red blood cells. Nature 2011, 469(7331):498-503. 10.1038/nature09702, 3040566, 21270888.
9. Okado-Matsumoto A, Matsumoto A, Fujii J, Taniguchi N. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem 2000, 127(3):493-501.
10. Chang X, Cui Y, Zong M, Zhao Y, Yan X, Chen Y, Han J. Identification of proteins with increased expression in rheumatoid arthritis synovial tissues. J Rheumatol 2009, 36(5):872-880. 10.3899/jrheum.080939, 19369474.
11. Schulte J, Struck J, Bergmann A, Köhrle J. Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum. Clin Chim Acta 2010, 411(17-18):1258-1263. 10.1016/j.cca.2010.05.016, 20493180.
12. Nickel CH, Ruedinger J, Misch F, Blume K, Maile S, Schulte J, Köhrle J, Hartmann O, Giersdorf S, Bingisser R. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department. Acad Emerg Med 2011, 18(8):851-859. 10.1111/j.1553-2712.2011.01126.x, 21843221.
13. Schulte J, Struck J, Köhrle J, Müller B. Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis. Shock 2011, 35(5):460-465. 10.1097/SHK.0b013e3182115f40, 21283059.
14. Soini Y, Haapasaari KM, Vaarala MH, Turpeenniemi-Hujanen T, Kärjä V, Karihtala P. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. Int J Clin Exp Pathol 2011, 4(3):267-275. 3071659, 21487522.
15. Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 2002, 8(7):2298-2305.
16. Karihtala P, Soini Y, Vaskivuo L, Bloigu R, Puistola U. DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma. Int J Gynecol Cancer 2009, 19(6):1047-1051. 10.1111/IGC.0b013e3181ad0f0d, 19820366.
17. Karihtala P, Kauppila S, Soini Y, Jukkola-Vuorinen A. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas. BMC Cancer 2011, 11:262. 10.1186/1471-2407-11-262, 3141776, 21693047.
18. Karihtala P, Mantyniemi A, Kang SW, Kinnula VL, Soini Y. Peroxiredoxins in breast carcinoma. Clin Cancer Res 2003, 9(9):3418-3424.
19. Chang KP, Yu JS, Chien KY, Lee CW, Liang Y, Liao CT, Yen TC, Lee LY, Huang LL, Liu SC, Chang YS, Chi LM. Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. J Proteome Res 2011, 10(11):4935-4947. 10.1021/pr200311p, 21859152.
20. Basu A, Banerjee H, Rojas H, Martinez SR, Roy S, Jia Z, Lilly MB, De León M, Casiano CA. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate 2011, 71(7):755-765. 10.1002/pros.21292, 21031435.
21. Dreja T, Jovanovic Z, Rasche A, Kluge R, Herwig R, Tung YC, Joost HG, Yeo GS, Al-Hasani H. Diet-induced gene expression of isolated pancreatic islets from a polygenic mouse model of the metabolic syndrome. Diabetologia 2010, 53(2):309-320. 10.1007/s00125-009-1576-4, 2797618, 19902174.
22. Jiang YL, Ning Y, Ma XL, Liu YY, Wang Y, Zhang Z, Shan CX, Xu YD, Yin LM, Yang YQ. Alteration of the proteome profile of the pancreas in diabetic rats induced by streptozotocin. Int J Mol Med 2011, 28(2):153-160.
23. Xie X, Li S, Liu S, Lu Y, Shen P, Ji J. Proteomic analysis of mouse islets after multiple low-dose streptozotocin injection. Biochim Biophys Acta 2008, 1784(2):276-284.
24. Wang X, Zhang S, Sun C, Yuan ZG, Wu X, Wang D, Ding Z, Hu R. Proteomic profiles of mouse neuro n2a cells infected with variant virulence of rabies viruses. J Microbiol Biotechnol 2011, 21(4):366-373.
25. Jamaluddin M, Wiktorowicz JE, Soman KV, Boldogh I, Forbus JD, Spratt H, Garofalo RP, Brasier AR. Role of peroxiredoxin 1 and peroxiredoxin 4 in protection of respiratory syncytial virus-induced cysteinyl oxidation of nuclear cytoskeletal proteins. J Virol 2010, 84(18):9533-9545. 10.1128/JVI.01005-10, 2937607, 20610706.
26. Knight M, Raghavan N, Goodall C, Cousin C, Ittiprasert W, Sayed A, Miller A, Williams DL, Bayne CJ. Biomphalaria glabrata peroxiredoxin: effect of Schistosoma mansoni infection on differential gene regulation. Mol Biochem Parasitol 2009, 167(1):20-31. 10.1016/j.molbiopara.2009.04.002, 2705950, 19439374.
27. Mota S, Mendes M, Freitas N, Penque D, Coelho AV, Cunha C. Proteome analysis of a human liver carcinoma cell line stably expressing hepatitis delta virus ribonucleoproteins. J Proteomics 2009, 72(4):616-627. 10.1016/j.jprot.2008.12.003, 19136081.
28. Young R, Hayes JD, Brown K, Wolf CR, Whitelaw CB. Peroxiredoxin gene expression signatures in liver reflect toxic insult. Assay Drug Dev Technol 2010, 8(4):512-517. 10.1089/adt.2009.0246, 20482376.
29. Anderson R, Schmidt R. Clinical biomarkers in sepsis. Front Biosci (Elite Ed) 2010, 2:504-520.
30. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med 2010, 49(11):1603-1616. 10.1016/j.freeradbiomed.2010.09.006, 2990475, 20840865.
31. Uno K, Nicholls SJ. Biomarkers of inflammation and oxidative stress in atherosclerosis. Biomark Med 2010, 4(3):361-373. 10.2217/bmm.10.57, 20550470.
32. Liu G, Botting CH, Evans KM, Walton JAG, Xu G, Slawin AMZ, Westwood NJ. Optimisation of conoidin A, a peroxiredoxin inhibitor. Chem Med Chem 2010, 5:41-45.
33. Mitsumoto A, Takanezawa Y, Okawa K, Iwamatsu A, Nakagawa Y. Variants of peroxiredoxins expression in response to hydroperoxide stress. Free Radic Biol Med 2001, 30(6):625-635. 10.1016/S0891-5849(00)00503-7, 11295360.
34. Lehtonen ST, Svensk AM, Soini Y, Paakko P, Hirvikoski P, Kang SW, Saily M, Kinnula VL. Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 2004, 111(4):514-521. 10.1002/ijc.20294, 15239128.
35. Huo R, He Y, Zhao C, Guo X-J, Lin M, Sha J-H. Identification of human spermatogenesis-related proteins by comparative proteomic analysis: a preliminary study. Fertil Steril 2008, 90(4):1109-1118. 10.1016/j.fertnstert.2007.07.1342, 18068167.
36. Matsuki S, Sasagawa I, Iuchi Y, Fujii J. Impaired expression of peroxiredoxin 4 in damaged testes by artificial cryptorchidism. Redox Rep 2002, 7(5):276-278. 10.1179/135100002125000785, 12688509.
37. Ikeda Y, Ito R, Ihara H, Okada T, Fujii J. Expression of N-terminally truncated forms of rat peroxiredoxin-4 in insect cells. Protein Expr Purif 2010, 72(1):1-7. 10.1016/j.pep.2010.02.001, 20144717.
38. O'Flaherty C, Rico de Souza A. Hydrogen peroxide modifies human sperm peroxiredoxins in a dose-dependent manner. Biol Reprod 2011, 84(2):238-247. 10.1095/biolreprod.110.085712, 20864641.
39. Yim SH, Kim YJ, Oh SY, Fujii J, Zhang Y, Gladyshev VN, Rhee SG. Identification and characterization of an alternatively transcribed form of peroxiredoxin IV that is specifically expressed in spermatids of the postpubertal mouse testis. J Biol Chem 2011, 286(45):39002-39012. 10.1074/jbc.M111.257220, 21835919.
40. Pérez-Sánchez J, Bermejo-Nogales A, Calduch-Giner JA, Kaushik S, Sitjà-Bobadilla A. Molecular characterization and expression analysis of six peroxiredoxin paralogous genes in gilthead sea bream (Sparus aurata): insights from fish exposed to dietary, pathogen and confinement stressors. Fish Shellfish Immunol 2011, 31(2):294-302. 10.1016/j.fsi.2011.05.015, 21640832.
41. Qiu L, Ma Z, Jiang S, Wang W, Zhou F, Huang J, Li J, Yang Q. Molecular cloning and mRNA expression of peroxiredoxin gene in black tiger shrimp (Penaeus monodon). Mol Biol Rep 2010, 37(6):2821-2827. 10.1007/s11033-009-9832-8, 19760093.
42. Hazane-Puch F, Benaraba R, Valenti K, Osman M, Laporte F, Favier A, Anderson RA, Roussel AM, Hininger-Favier I. Chromium III histidinate exposure modulates gene expression in HaCaT human keratinocytes exposed to oxidative stress. Biol Trace Elem Res 2010, 137(1):23-39. 10.1007/s12011-009-8557-9, 19902159.
43. Diet A, Abbas K, Bouton C, Guillon B, Tomasello F, Fourquet S, Toledano MB, Drapier JC. Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages. J Biol Chem 2007, 282(50):36199-36205. 10.1074/jbc.M706420200, 17921138.
44. Pylväs M, Puistola U, Kauppila S, Soini Y, Karihtala P. Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis. Eur J Cancer 2010, 46(9):1661-1667. 10.1016/j.ejca.2010.02.006, 20206498.
45. Hayder N, Bouhlel I, Skandrani I, Kadri M, Steiman R, Guiraud P, Mariotte AM, Ghedira K, Dijoux-Franca MG, Chekir-Ghedira L. In vitro antioxidant and antigenotoxic potentials of myricetin-3-o-galactoside and myricetin-3-o-rhamnoside from Myrtus communis: modulation of expression of genes involved in cell defence system using cDNA microarray. Toxicol In Vitro 2008, 22(3):567-581. 10.1016/j.tiv.2007.11.015, 18222061.
46. Hansen J, Palmfeldt J, Vang S, Corydon TJ, Gregersen N, Bross P. Quantitative proteomics reveals cellular targets of celastrol. PLoS One 2011, 6(10):e26634. 10.1371/journal.pone.0026634, 3202559, 22046318.
47. Yerbury JJ, Stewart EM, Wyatt AR, Wilson MR. Quality control of protein folding in extracellular space. EMBO Rep 2005, 6(12):1131-1136. 10.1038/sj.embor.7400586, 1369217, 16319958.
48. Palande K, Roovers O, Gits J, Verwijmeren C, Iuchi Y, Fujii J, Neel BG, Karisch R, Tavernier J, Touw IP. Peroxiredoxin-controlled G-CSF signalling at the endoplasmic reticulum-early endosome interface. J Cell Sci 2011, 124(Pt 21):3695-3705.
49. Park JJ, Chang HW, Jeong EJ, Roh JL, Choi SH, Jeon SY, Ko GH, Kim SY. Peroxiredoxin IV protects cells from radiation-induced apoptosis in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2009, 73(4):1196-1202. 10.1016/j.ijrobp.2008.10.070, 19251091.
50. Wang HQ, Du ZX, Liu BQ, Gao YY, Meng X, Guan Y, Zhang HY. TNF-related apoptosis-inducing ligand suppresses PRDX4 expression. FEBS Lett 2009, 583(9):1511-1515. 10.1016/j.febslet.2009.04.009, 19364504.
51. Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, Waltmire CN, Crowley C, Dvorakova K, Bernstein C, Craven M, Garewal H, Bernstein H. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis 2002, 23(12):2063-2080. 10.1093/carcin/23.12.2063, 12507930.
52. Lee YS, Chang HW, Jeong JE, Lee SW, Kim SY. Proteomic analysis of two head and neck cancer cell lines presenting different radiation sensitivity. Acta Otolaryngol 2008, 128(1):86-92. 10.1080/00016480601110196, 17917836.
53. Shen C, Nathan C. Nonredundant antioxidant defense by multiple two-cysteine peroxiredoxins in human prostate cancer cells. Mol Med 2002, 8(2):95-102. 2039972, 12080185.